Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Altered CD45 expression in malignant B-1 cells

A M Dang1, J A Phillips, T Lin

  • 1Department of Pathology, UMDNJ/New Jersey Medical School, Newark 07103, USA.

Cellular Immunology
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cystic fibrosis in Afro-Brazilians: XK haplotypes analysis supports the European origin of p.F508del mutation.

Genetica·2017
Same author

Whole exome sequencing identifies multiple diagnoses in congenital glaucoma with systemic anomalies.

Clinical genetics·2016
Same author

Naive ophiophagus lizards recognize and avoid venomous snakes using chemical cues.

Journal of chemical ecology·2013
Same author

Expansion of genetic services utilizing a general genetic counseling clinic.

Journal of genetic counseling·2013
Same author

Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2011
Same author

22q13.3 deletion syndrome: clinical and molecular analysis using array CGH.

American journal of medical genetics. Part A·2010
Same journal

Retraction notice to "Myeloid-derived suppressor cells accumulate in the liver site after sepsis to induce immunosuppression" Cellular Immunology 279 (2012) 12-20.

Cellular immunology·2026
Same journal

The uptake, intracellular trafficking and recycling of FcRn-blocking therapeutics in human endothelial cells in vitro.

Cellular immunology·2026
Same journal

Exosome-mediated immune modulation in rheumatoid arthritis and its role in synovial inflammation and autoimmune amplification.

Cellular immunology·2026
Same journal

Persistent CD4<sup>+</sup> T cell hyporesponsiveness during recovery from prolonged symptomatic SARS-CoV-2 infection.

Cellular immunology·2026
Same journal

Deficit in blood MAIT cells, altered cytokines and T cell dynamics in patients with coronary artery disease.

Cellular immunology·2026
Same journal

The circ_0003692-miR-1197-TLR4 axis: A key regulator in rheumatoid arthritis proliferation and inflammation.

Cellular immunology·2026
See all related articles

Altered CD45 expression, a key protein in B cell signaling, is linked to the development of B-1 malignancies in NZB mice. Reduced CD45 levels and abnormal isoform B220/6B2 expression are associated with malignant B-1 cell growth.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • CD45 is a crucial surface glycoprotein with tyrosine phosphatase activity, vital for B cell receptor signaling, proliferation, and differentiation.
  • NZB mice serve as a model for human chronic lymphocytic leukemia, exhibiting spontaneous B-1 cell hyperproliferation and malignancy.
  • Malignant B-1 cells in NZB mice display distinct phenotypic characteristics, including reduced CD45 and altered B220/6B2 isoform expression compared to normal B cells.

Purpose of the Study:

  • To investigate the role of CD45 expression in the development of B-1 malignancies in NZB mice.
  • To analyze the expression patterns of CD45 isoforms, particularly B220/6B2, in malignant versus nonmalignant B cells.
  • To determine if abnormal CD45 expression is a prerequisite for malignant transformation and tumor growth.

Related Experiment Videos

Main Methods:

  • Phenotypic analysis of B cell populations using flow cytometry to assess IgM and CD45/B220/6B2 expression levels.
  • Quantitative analysis of CD45 and IgM RNA levels via RT-PCR.
  • Western blot analysis to evaluate CD45/B220 protein expression and identify potential posttranslational modifications.
  • In vivo adoptive transfer experiments using sorted B-1 cells into F1 recipients to assess the impact on malignancy development.

Main Results:

  • Malignant NZB B-1 cells exhibit reduced CD45 levels and dull/negative B220/6B2 expression compared to normal B cells.
  • Malignant B-1 cells show decreased CD45 RNA relative to IgM, while nonmalignant B-2 cells have similar RNA levels for both.
  • Western blot analysis suggests a posttranslational glycosylation defect in CD45/B220 expression on malignant B-1 cells.
  • Adoptive transfer of IgMhi, B220/6B2-negative B-1 cells led to earlier development of malignant clones in recipients.

Conclusions:

  • Abnormal CD45 expression, including reduced levels and altered isoform usage (B220/6B2 negativity), is strongly associated with B-1 cell malignancy in NZB mice.
  • These CD45 alterations may be a critical prerequisite for the long-term growth and malignant transformation of B-1 cells.
  • Dysregulation of CD45 function likely contributes to abnormal proliferation and signaling in malignant B-1 cells, impacting disease progression.